Is Taurolidine-citrate an effective and cost-effective hemodialysis catheter lock solution? A systematic review and cost-effectiveness analysis

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

KAVOSI ZAHRA; Sarikhani Khorrami Maryam; KESHAVARZ KHOSRO; JAFARI ABDOSALEH; HASHEMI MESHKINI AMIR; Safaei Hamid Reza; NIKFAR SHEKOUFEH

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Medical Journal of The Islamic Republic of Iran Year:2016 | Volume:30 | Issue:1 Page(s): 0-0

Download Full-Text

View:

196

Download:

Cites:

Information Journal Paper

Title

Is Taurolidine-citrate an effective and cost-effective hemodialysis catheter lock solution? A systematic review and cost-effectiveness analysis

Author(s)

Keywords

Taurolidine-Citrate

Taurolock

Health Technology Assessment

Cost-effectiveness

Abstract

Background: Prevention of catheter-related infection is of prime importance, . However, because of the risks caused by the leakage of circulating antibiotics and development of resistance to antibiotics, they are replaced by lock solutions. The aim of this study was to evaluate the efficacy and Cost-effectiveness of Taurolidine-Citrate as a hemodialysis catheter lock solution compared to other common alternatives in Iran. Methods: To evaluate the efficacy of Taurolidine-Citrate, a systematic review was conducted by searching electronic databases. The outcomes of interest for Cost-effectiveness analysis were as follows: “ Catheter-related bacteremia episodes” ; “ catheter-related bacteremia-free survival” ; “ catheter thrombosis rate” for efficacy evaluation and "reduction of catheter-related infection". For evidence synthesis, a meta-analysis was conducted on the extracted efficacy data. To evaluate the cost of treatments, direct medical costs were included, and the incremental Cost-effectiveness ratio was calculated for each comparison. The payers’ (patients and insurance companies) perspectives were used for cost analysis. Results: After carrying out the systematic process, three articles were included in the analysis. Considering 95% confidence interval, the relative difference was-0. 16 (-0. 25 to-0. 07) for catheterrelated bacteremia episode, indicating that the rate of catheter-related infections in hemodialysis patients who used Taurolidine-Citrate was 16% less than in those hemodialysis patients who received heparin. Considering 95% confidence interval, the relative difference was 0. 13 (-0. 06 0. 32) for catheter thrombosis, showing that the rate of catheter-related thrombosis in hemodialysis patients who used Taurolidine-Citrate was 13% more than in hemodialysis patients who received heparin. The results of this analysis indicated that Taurolidine-Citrate, compared to heparin, was more effective in preventing catheter-related infection; therefore, it could be considered as a superior strategy. Nevertheless, compared to heparin-gentamicin combination, Taurolidine-Citrate is an inferior strategy because of its higher cost and lower infection prevention. Conclusion: Compared to heparin, Taurolidine-Citrate is a superior option, but it is an inferior strategy compared to heparin-gentamicin combination. The clinical evidences on Taurolidine-Citrate, heparin and gentamicin/heparin are not sufficient for making confident decisions.

Cites

Self-care Agency and Its Influential Factors in Hemodialysis Patients

References

No record.

Cite

APA: Copy

KAVOSI, ZAHRA, Sarikhani Khorrami, Maryam, KESHAVARZ, KHOSRO, JAFARI, ABDOSALEH, HASHEMI MESHKINI, AMIR, Safaei, Hamid Reza, & NIKFAR, SHEKOUFEH. (2016). Is Taurolidine-citrate an effective and cost-effective hemodialysis catheter lock solution? A systematic review and cost-effectiveness analysis. MEDICAL JOURNAL OF THE ISLAMIC REPUBLIC OF IRAN (MJIRI), 30(1), 0-0. SID. https://sid.ir/paper/294596/en

Vancouver: Copy

KAVOSI ZAHRA, Sarikhani Khorrami Maryam, KESHAVARZ KHOSRO, JAFARI ABDOSALEH, HASHEMI MESHKINI AMIR, Safaei Hamid Reza, NIKFAR SHEKOUFEH. Is Taurolidine-citrate an effective and cost-effective hemodialysis catheter lock solution? A systematic review and cost-effectiveness analysis. MEDICAL JOURNAL OF THE ISLAMIC REPUBLIC OF IRAN (MJIRI)[Internet]. 2016;30(1):0-0. Available from: https://sid.ir/paper/294596/en

IEEE: Copy

ZAHRA KAVOSI, Maryam Sarikhani Khorrami, KHOSRO KESHAVARZ, ABDOSALEH JAFARI, AMIR HASHEMI MESHKINI, Hamid Reza Safaei, and SHEKOUFEH NIKFAR, “Is Taurolidine-citrate an effective and cost-effective hemodialysis catheter lock solution? A systematic review and cost-effectiveness analysis,” MEDICAL JOURNAL OF THE ISLAMIC REPUBLIC OF IRAN (MJIRI), vol. 30, no. 1, pp. 0–0, 2016, [Online]. Available: https://sid.ir/paper/294596/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops